ERBB2 and breast carcinoma: In epidermal growth factor receptor 2 (HER-2)-positive breast cancer, HER-2-induced expression of macroH2A1.2, but not macroH2A1.1, amplified HER-2 activity, suggesting a potential positive feedback loop [141].